Fortis Frontier PLC

("Fortis Frontier" or the "Company")

Publication of Circular

Related Party Transaction

Notice of General Meeting

Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly MyHealthChecked PLC), announces that a Circular has today been published containing the notice of a general meeting to be held at the offices of BPE Solicitors LLP, St James House, St James Square, Cheltenham GL50 3PR at 10.30 a.m. on 28 April 2026, following the conclusion of the Annual General Meeting scheduled for 10.00 a.m. that day.

Fortis Frontier PLC has entered into two conditional agreements, the EIS Buyback Agreement and the GP Buyback Agreement (together the "Buyback Agreements") to purchase 13,717,619 Ordinary Shares (the "Buyback") in aggregate from Mercia at a price of 9.0 pence per Ordinary Share for a total cost of approximately £1,234,586. The Buyback will be funded from the Company's surplus cash balances.

The Circular provides Shareholders with the background and reasons for the Buyback and explains why the Directors consider the Buyback to be in the best interests of the Company and its Shareholders as a whole. The Circular also sets out the reasons why the Directors believe the terms of the Buyback are fair and reasonable to the Independent Shareholders who will not participate in the transaction, and to recommend that the Independent Shareholders vote in favour of the Resolutions to be proposed at the General Meeting.

The Directors, having carefully reviewed alternative uses for the Company's cash resources, are firmly of the view that the Buyback as proposed is a good use of capital at this time and will be value-enhancing for Shareholders.

Under Sections 693(1) and 694(2) of the Act, each of the Buyback Agreements is required to be approved by the Independent Shareholders (i.e all shareholders entitled to vote except for Mercia) by way of ordinary resolution. Therefore, each of the Resolutions to be proposed at the General Meeting is an ordinary resolution pursuant to which the Independent Shareholders are being asked to approve each of the Buyback Agreements for the purpose of section 694(2) of the Act. Resolution 1 is to approve the EIS Buyback Agreement and Resolution 2 is to approve the GP Buyback Agreement.

Related Party Transaction

Mercia is a "substantial shareholder" of the Company for the purposes of the AIM Rules for Companies, and is therefore treated as a "related party" under the AIM Rules. The Buyback is therefore a related party transaction.

In accordance with AIM Rule 13, the Directors consider, having consulted with the Company's nominated adviser, SPARK Advisory Partners Limited, that the terms of the purchase of such Ordinary Shares pursuant to each of the Buyback Agreements are fair and reasonable insofar as the Company's Shareholders are concerned.

Only registered shareholders are entitled to attend the General Meeting. Any shareholders who wish to attend the meeting should email [email protected] with their proof of shareholding to register for the meeting.

The Circular and Notice of General Meeting will be posted to Shareholders today and will also be available shortly on the Company's website: www.fortisfrontierplc-ir.com

Unless otherwise defined, all definitions used in this announcement will have the same meaning as described in the Circular.

For further information contact:

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell, as defined in the AIM Rules for Companies. On the same day the Company changed its name to Fortis Frontier PLC. The Board is now carefully considering the strategic options available to it in order to maximise shareholder value.

Definitions